GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Comedian Nikki Glaser, host of the 2025 Golden Globe Awards ceremony, dove right in at the start of her opening monologue: ...

Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

As India steps into 2025, breakthrough weight-loss drugs, economic shifts, and global trends shape the road to a Viksit ...

Novo Nordisk has filed for approval to extend the labelling for Saxenda to include children aged six to 11. There are concerns about the use of pharmacological interventions like Saxenda to treat ...

Novo Nordisk has received European approval for a new indication of its drug, Ozempic. The European Medicines Agency (EMA) has authorized a label expansion to include the treatment of chronic ...

A first-in-class pain med and blockbusters with new indications are just a few of the possible approvals to keep an eye on in ...

A first-in-class pain med and blockbusters with new indications are just a few of the possible approvals to keep an eye on in ...

In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...

DelveInsight's Mild Cognitive Impairment Market Insights report includes a comprehensive understanding of current treatment ...

SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the "Company”) announced today that its SomaScan™ Platform played a pivotal role in a study ...